Self-Jing Fang stiff ginkgo treatment of cough variant asthma clinical observation_0.docVIP

 PAGE \* MERGEFORMAT 9 Self-Jing Fang stiff ginkgo treatment of cough variant asthma clinical observation Of: Wen-Jie Feng, Xiang-Lin Li, Chen Liru, Zhang Lixin, Wang Shuying, Yuan Zhicheng, Yao Bing-Shan [Keywords:] cough variant asthma; Jing stiff ginkgo side; bronchial provocation test; Chinese medicine Cough variant asthma (CVA) is a special type of asthma, is a type of inflammation of the airways caused by allergy to cough as the main performance, but also can be seen throat itching, shortness of breath and other symptoms typical of asthma can also develop , is a type of subacute or chronic cough [1] category. modern medicine mainly in the inhaled corticosteroid and oral theophylline, β agonist-based, long course of treatment, the effect is unsatisfactory, coupled with the fear hormone side effects, patients often refuse applications. I Treatment of stiff ginkgo by Jing CVA 80 patients with inhaled budesonide plus theophylline were observed for oral treatment, are reported below. 1 Materials and Methods 1.1 Case Selection Line with the Chinese Medical Association Respiratory Diseases credits will be developed asthma “cough diagnosis and treatment guidelines” [2] diagnostic criteria for CVA: ① chronic cough, often accompanied by stimulation of type cough at night; ② bronchial provocation test was positive; ③ breath peak flow (PEF) variation rate of the daygt; = 20%; ④ rule out other causes of chronic cough. Before treatment application CHESTGRAPH HI-101 spirometer checks, by the same experienced doctor to complete testing, PEF variation rates of the daygt; = 20% of selected cases, provocation tests with different concentrations of histamine inhalation, using high-pressure oxygen as a driving force source, 50 psi, 5 L / min, the preparation of histamine concentration 0.03,0.06,0.125,0.25,0.5,1.0,2.0,4.0,8.0 mg / mL, to prepare for testing [3]. Airway measured before treatment reaction conditions, with tidal method to PC20-FEV1 (FEV1 decr